| 摘要 |
<p>Recombinant fusion proteins containing at least one domain which confers targeting properties on the fusion protein, together with at least one peptide sequence that is a substrate for a protein kinase, can be labeled with ?32P or 33¿P by treatment with a protein kinase and a ?32P- or 33¿P-labeled phosphate donor. The labeled targeting proteins bind specifically to diseased cells or tissue, which are killed by the radiation from the ?32P or 33¿P.</p> |
